Neural transplantation for treatment of Parkinson's disease

被引：35

作者：

Borlongan, CV ^{[1
]}

Sanberg, PR

机构：

[1] Med Coll Georgia, Dept Neurobiol, Augusta, GA 30912 USA

[2] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA

[3] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL 33612 USA

来源：

DRUG DISCOVERY TODAY | 2002年 / 7卷 / 12期

关键词：

D O I：

10.1016/S1359-6446(02)02297-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Neural transplantation has emerged as an efficacious experimental treatment for CNS disorders, especially Parkinson's disease. However, logistical and ethical issues impede large-scale clinical trials. To this end, alternatives to human fetal cells as donor cell grafts have been examined, including xenografts, stem cells, genetically engineered cells, immortalized cell lines, or paraneural cells that secrete specific neurotrophic or growth factors. Accumulating evidence also suggests that exogenous treatment with neurotrophic or growth factors, immunosuppressants, free radical scavengers, and anti-apoptotic agents can enhance survival and functional effects of the grafts, This article will review recent studies demonstrating the potential of these alternative cell graft sources and novel drugs for treating Parkinson's disease.

引用

页码：674 / 682

页数：9

共 61 条

[41] Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine [J].

Matsuura, K ;

Makino, H ;

Ogawa, N .

EXPERIMENTAL NEUROLOGY, 1997, 146 (02) :526-535

[42] Purification of adrenal chromaffin cells increases antinociceptive efficacy of xenotransplants without immunosuppression [J].

Michalewicz, P ;

Laurito, CE ;

Pappas, GD ;

Lu, Y ;

Yeomans, DC .

CELL TRANSPLANTATION, 1999, 8 (01) :103-109

[43] Histochemical detection of apoptosis in Parkinson's disease [J].

Mochizuki, H ;

Goto, K ;

Mori, H ;

Mizuno, Y .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 137 (02) :120-123

[44] OVEREXPRESSING CU/ZN SUPEROXIDE-DISMUTASE ENHANCES SURVIVAL OF TRANSPLANTED NEURONS IN A RAT MODEL OF PARKINSONS-DISEASE [J].

NAKAO, N ;

FRODL, EM ;

WIDNER, H ;

CARLSON, E ;

EGGERDING, FA ;

EPSTEIN, CJ ;

BRUNDIN, P .

NATURE MEDICINE, 1995, 1 (03) :226-231

[45] Role of basic FGF and oxygen in control of proliferation, survival, and neuronal differentiation in carotid body chromaffin cells [J].

Nurse, CA ;

Vollmer, C .

DEVELOPMENTAL BIOLOGY, 1997, 184 (02) :197-206

[46] Motor fluctuations and dyskinesia in Parkinson's disease [J].

Nutt, JG .

PARKINSONISM & RELATED DISORDERS, 2001, 8 (02) :101-108

[47] Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity [J].

Offen, D ;

Beart, PM ;

Cheung, NS ;

Pascoe, CJ ;

Hochman, A ;

Gorodin, S ;

Melamed, E ;

Bernard, R ;

Bernard, O .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (10) :5789-5794

[48] Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient [J].

Piccini, P ;

Brooks, DJ ;

Björklund, A ;

Gunn, RN ;

Grasby, PM ;

Rimoldi, O ;

Brundin, P ;

Hagell, P ;

Rehncrona, S ;

Widner, H ;

Lindvall, O .

NATURE NEUROSCIENCE, 1999, 2 (12) :1137-1140

[49] Efficacy of grafted immortalized dopamine neurons in an animal model of Parkinsonism: A review [J].

Prasad, KN ;

Clarkson, ED ;

La Rosa, FG ;

Edwards-Prasad, J ;

Freed, CR .

MOLECULAR GENETICS AND METABOLISM, 1998, 65 (01) :1-9

[50] Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain [J].

Sanberg, PR ;

Borlongan, CV ;

Saporta, S ;

Cameron, DF .

NATURE BIOTECHNOLOGY, 1996, 14 (13) :1692-1695

← 1 2 3 4 5 6 7 →